This inventor holds 5 USPTO granted patents, plus 1 CIPO patent. Top assignee: University of California. Active years: 2013-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2019
Title: Zhenhua Li: Innovator in Cancer Immunotherapy
Introduction
Zhenhua Li is a prominent inventor based in Los Angeles, CA (US). He has made significant contributions to the field of cancer immunotherapy, holding a total of 5 patents. His work focuses on developing innovative solutions that target cancer cells, enhancing the effectiveness of treatment modalities.
Latest Patents
One of his latest patents is a fusion molecule based on a tumor-associated antigen (TAA) variant. This invention provides novel carbonic anhydrase (CAIX) nucleic acid and peptide sequences, along with related methods and compositions. These include anti-cancer immunogenic agents, such as vaccines and chimeric molecules, designed to elicit an immune response specifically directed against cancer cells expressing a CAIX antigenic marker. The novel CAIX variant and its related compositions are applicable in various treatment modalities, including protein vaccination, DNA vaccination, and adoptive immunotherapy.
Another significant patent by Zhenhua Li is also centered around a fusion molecule based on a novel TAA variant. Similar to his previous work, this invention offers innovative CAIX nucleic acid and peptide sequences, as well as methods and compositions that serve as anti-cancer immunogenic agents. The focus remains on eliciting an immune response against cancer cells that express the CAIX antigenic marker, further expanding the potential for effective cancer treatments.
Career Highlights
Zhenhua Li is affiliated with the University of California, where he continues to advance his research in cancer immunotherapy. His work has garnered attention for its potential to revolutionize treatment options for cancer patients.
Collaborations
Zhenhua Li collaborates with notable professionals in his field, including Arie S Belldegrun. Their combined expertise contributes to the development of innovative cancer therapies.
Conclusion
Zhenhua Li's contributions to cancer immunotherapy through his patents and research at the University of California highlight his role as a leading inventor in the field. His innovative approaches have the potential to significantly impact cancer treatment and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile